ADARx Pharmaceuticals, Inc. (ADRX) stock
ADRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Last filing: 10-Q on Nov 12, 2026
$14.16+1.34 (+10.45%)
Close on Nov 19, 2026Market cap $1.52BP/E –Yield –
ADARx Pharmaceuticals gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for ADARx Pharmaceuticals
ADARx Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?